BIOA (STOCKS)
BioAge Labs, Inc. Common Stock
$20.000000
+1.960000 (+10.86%)
Prev close: $18.040000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kristen Fortney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $883.05M
- Employees
- 64
- P/E (TTM)
- -7.50
- P/B (TTM)
- 2.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $10.32M |
| Benefits Costs and Expenses | $54.05M |
| Costs And Expenses | $106.42M |
| Nonoperating Income/Loss | $11.78M |
| Operating Expenses | $112.03M |
| Research and Development | $83.27M |
| Other Operating Expenses | $28.76M |
| Operating Income/Loss | -$101.71M |
| Income/Loss From Continuing Operations After Tax | -$89.93M |
| Income/Loss From Continuing Operations Before Tax | -$67.71M |
| Net Income/Loss | -$89.93M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$89.93M |
| Net Income/Loss Available To Common Stockholders, Basic | -$89.93M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.40 |
| Diluted Earnings Per Share | -$2.40 |
| Basic Average Shares | 114,263,439 |
| Diluted Average Shares | 114,263,439 |
| Assets | $397.65M |
| Current Assets | $391.86M |
| Noncurrent Assets | $5.79M |
| Fixed Assets | $1.12M |
| Other Non-current Assets | $4.68M |
| Liabilities | $18.53M |
| Current Liabilities | $15.83M |
| Accounts Payable | $3.07M |
| Wages | $1.62M |
| Other Current Liabilities | $11.15M |
| Noncurrent Liabilities | $2.71M |
| Equity | $379.12M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $379.12M |
| Liabilities And Equity | $397.65M |
| Net Cash Flow From Operating Activities | -$88.31M |
| Net Cash Flow From Operating Activities, Continuing | -$88.31M |
| Net Cash Flow From Investing Activities | -$63.98M |
| Net Cash Flow From Investing Activities, Continuing | -$63.98M |
| Net Cash Flow From Financing Activities | $136.68M |
| Net Cash Flow From Financing Activities, Continuing | $136.68M |
| Net Cash Flow | -$15.61M |
| Net Cash Flow, Continuing | -$15.61M |
| Comprehensive Income/Loss | -$90.07M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$90.12M |
| Other Comprehensive Income/Loss | -$20.31M |
| Other Comprehensive Income/Loss Attributable To Parent | -$191.00K |